• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭合并心房颤动住院患者出院时的预后最佳心率

Prognostically Optimal Heart Rate at Discharge in Hospitalized Patients With Heart Failure and Atrial Fibrillation.

作者信息

Kishihara Makoto, Kawakami Ryoko, Fukushima Noritoshi, Abe Takuro, Takada Takuma, Shirotani Shota, Yoshida Ayano, Hata Takehiro, Watanabe Shonosuke, Kawamoto Takanori, Hasegawa Shun, Yamaguchi Junichi, Jujo Kentaro

机构信息

Department of Cardiology, Saiseikai Kazo Hospital, Saitama, Japan.

Physical Fitness Research Institute, Meiji Yasuda Life Foundation of Health and Welfare, Tokyo, Japan.

出版信息

JACC Adv. 2024 Jul 24;3(8):101120. doi: 10.1016/j.jacadv.2024.101120. eCollection 2024 Aug.

DOI:10.1016/j.jacadv.2024.101120
PMID:39156115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11327451/
Abstract

BACKGROUND

Managing heart rate (HR) is crucial for enhancing clinical prognosis in patients with heart failure (HF) and atrial fibrillation (AF). Nevertheless, the prognostic impact of HR at discharge in hospitalized HF patients remains unclear.

OBJECTIVES

This study aimed to determine the HR associated with the lowest risk of death and HF in patients hospitalized with HF and AF.

METHODS

In this observational study, 334 persistent AF patients were analyzed from a database of 1,930 consecutive HF hospitalizations. Exclusion criteria included sinus rhythm or paroxysmal AF, cardiac pacemakers, or unrecorded HR at discharge. Participants were divided into four groups based on HR at discharge in 10 beats/min increments. The primary endpoint was a composite of death from any cause and rehospitalization due to HF. The association between resting HR and the primary endpoint was determined using Kaplan-Meier analysis and Cox proportional hazards models.

RESULTS

The median follow-up period was 389 days, with 133 patients (39.8%) reaching the primary endpoint. Kaplan-Meier analysis revealed a significantly higher primary endpoint incidence in patients with HR >81 beats/min at discharge compared to those with HR <60 beats/min (log-rank test for trend:  = 0.039). Multivariable Cox regression analysis showed that HR >81 beats/min at discharge was associated with the primary endpoint, with a hazard ratio of 1.79 (95% CI: 1.04-3.07), compared to HR <60 beats/min.

CONCLUSIONS

The findings suggest that controlling HR to less than 80 beats/min at discharge may lead to better clinical outcomes in patients with HF and persistent AF.

摘要

背景

控制心率(HR)对于改善心力衰竭(HF)合并心房颤动(AF)患者的临床预后至关重要。然而,住院HF患者出院时心率对预后的影响仍不明确。

目的

本研究旨在确定HF合并AF住院患者中与死亡和HF风险最低相关的心率。

方法

在这项观察性研究中,从1930例连续性HF住院患者数据库中分析了334例持续性AF患者。排除标准包括窦性心律或阵发性AF、心脏起搏器或出院时未记录心率。根据出院时心率以10次/分钟为增量将参与者分为四组。主要终点是任何原因导致的死亡和因HF再次住院的复合终点。使用Kaplan-Meier分析和Cox比例风险模型确定静息心率与主要终点之间的关联。

结果

中位随访期为389天,133例患者(39.8%)达到主要终点。Kaplan-Meier分析显示,出院时心率>81次/分钟的患者主要终点发生率显著高于心率<60次/分钟的患者(趋势对数秩检验:=0.039)。多变量Cox回归分析显示,出院时心率>81次/分钟与主要终点相关,与心率<60次/分钟相比,风险比为1.79(95%CI:1.04-3.07)。

结论

研究结果表明,将HF合并持续性AF患者出院时心率控制在80次/分钟以下可能会带来更好的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/5e92e0ae226a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/5e92e0ae226a/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/6ccfda235be9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/5e92e0ae226a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/5e92e0ae226a/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/6ccfda235be9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f0a/11327451/5e92e0ae226a/gr2.jpg

相似文献

1
Prognostically Optimal Heart Rate at Discharge in Hospitalized Patients With Heart Failure and Atrial Fibrillation.心力衰竭合并心房颤动住院患者出院时的预后最佳心率
JACC Adv. 2024 Jul 24;3(8):101120. doi: 10.1016/j.jacadv.2024.101120. eCollection 2024 Aug.
2
Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction.射血分数轻度降低的心力衰竭伴心房颤动的预后和治疗策略。
Eur J Prev Cardiol. 2024 Aug 22;31(11):1372-1384. doi: 10.1093/eurjpc/zwae185.
3
Discharge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation.心力衰竭合并心房颤动患者的出院心率与 1 年临床结局。
Chin Med J (Engl). 2022 Jan 5;135(1):52-62. doi: 10.1097/CM9.0000000000001768.
4
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭伴射血分数降低患者的房颤类型与结局。
J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.
5
Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.心率决定β受体阻滞剂对心力衰竭合并心房颤动患者心血管结局的有益影响。
Hypertens Res. 2019 Nov;42(11):1716-1725. doi: 10.1038/s41440-019-0289-4. Epub 2019 Jun 18.
6
Variation in heart rate range by 24-h Holter monitoring predicts heart failure in patients with atrial fibrillation.24 小时动态心电图监测的心率变异性预测心房颤动患者心力衰竭。
ESC Heart Fail. 2022 Oct;9(5):3092-3100. doi: 10.1002/ehf2.14035. Epub 2022 Jun 24.
7
Atrial fibrillation type and long-term clinical outcomes in hospitalized patients with heart failure: insight from JROADHF.住院心力衰竭患者的心房颤动类型与长期临床结局:来自 JROADHF 的观察。
Eur Heart J Qual Care Clin Outcomes. 2024 May 22;10(3):193-202. doi: 10.1093/ehjqcco/qcae005.
8
Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭住院患者的心率与预后
J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.
9
Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.静息心率在射血分数降低的心力衰竭合并心房颤动患者中的预后意义
Heart Vessels. 2020 Aug;35(8):1109-1115. doi: 10.1007/s00380-020-01573-5. Epub 2020 Mar 6.
10
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.在有房颤病史的患者中,新发心力衰竭的预测因素及其预后意义。
JACC Heart Fail. 2017 Jan;5(1):44-52. doi: 10.1016/j.jchf.2016.09.016.

引用本文的文献

1
Effects of strict versus lenient rate control on exercise capacity in atrial fibrillation: a retrospective analysis.严格与宽松心率控制对心房颤动患者运动能力的影响:一项回顾性分析
BMC Cardiovasc Disord. 2025 Jul 9;25(1):501. doi: 10.1186/s12872-025-04961-9.
2
Prognostic Significance of Ventricular Rate at Discharge in Patients With Persistent Atrial Fibrillation and HF.持续性心房颤动合并心力衰竭患者出院时心室率的预后意义
JACC Adv. 2024 Jul 30;3(8):101121. doi: 10.1016/j.jacadv.2024.101121. eCollection 2024 Aug.

本文引用的文献

1
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
2
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
3
Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.静息心率在射血分数降低的心力衰竭合并心房颤动患者中的预后意义
Heart Vessels. 2020 Aug;35(8):1109-1115. doi: 10.1007/s00380-020-01573-5. Epub 2020 Mar 6.
4
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
5
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新:美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
6
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
7
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.心房颤动引发心力衰竭,反之亦然:射血分数保留与降低时的时间关联及差异
Circulation. 2016 Feb 2;133(5):484-92. doi: 10.1161/CIRCULATIONAHA.115.018614. Epub 2016 Jan 8.
8
Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.静息心率及β受体阻滞剂的使用在射血分数降低的心力衰竭患者房颤和窦性心律中的预后意义:来自瑞典心力衰竭登记处的研究结果
Circ Heart Fail. 2015 Sep;8(5):871-9. doi: 10.1161/CIRCHEARTFAILURE.115.002285. Epub 2015 Aug 4.
9
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组及心律学会的报告
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28.
10
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.依伐布雷定治疗慢性心力衰竭的疗效评价(SHIFT):一项随机、安慰剂对照研究
Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1.